位置:首页 > 蛋白库 > ENSA_HUMAN
ENSA_HUMAN
ID   ENSA_HUMAN              Reviewed;         121 AA.
AC   O43768; A8K1Z9; E9PB69; Q5T5H2; Q68D48; Q6FHW0; Q6IAM4; Q6NUL2; Q6VUC6;
AC   Q6VUC7; Q6VUC8; Q6VUC9; Q6VUD0; Q6VUD1; Q9NRZ0;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1998, sequence version 1.
DT   03-AUG-2022, entry version 169.
DE   RecName: Full=Alpha-endosulfine;
DE   AltName: Full=ARPP-19e;
GN   Name=ENSA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   PHOSPHORYLATION.
RC   TISSUE=Brain;
RX   PubMed=9653196; DOI=10.1073/pnas.95.14.8387;
RA   Heron L., Virsolvy A., Peyrollier K., Gribble F.M., Le Cam A.,
RA   Ashcroft F.M., Bataille D.;
RT   "Human alpha-endosulfine, a possible regulator of sulfonylurea-sensitive
RT   K(ATP) channel: molecular cloning, expression and biological properties.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8387-8391(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10480622; DOI=10.2337/diabetes.48.9.1873;
RA   Heron L., Virsolvy A., Apiou F., Le Cam A., Bataille D.;
RT   "Isolation, characterization, and chromosomal localization of the human
RT   ENSA gene that encodes alpha-endosulfine, a regulator of beta-cell K(ATP)
RT   channels.";
RL   Diabetes 48:1873-1876(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORMS 1; 2; 3;
RP   5; 7 AND 8), AND TISSUE SPECIFICITY.
RX   PubMed=14728987; DOI=10.1016/j.ymgme.2003.09.013;
RA   Thameem F., Farook V.S., Yang X., Lee Y.-H., Permana P.A., Bogardus C.,
RA   Prochazka M.;
RT   "The transcribed endosulfine alpha gene is located within a type 2
RT   diabetes-linked region on 1q: sequence and expression analysis in Pima
RT   Indians.";
RL   Mol. Genet. Metab. 81:16-21(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Zhang Q., Fu G., Wu J., Zhou J., Ye M., Shen Y., Kan L., He K., Gu B.,
RA   Chen S., Mao M., Chen Z.;
RT   "Human alpha endosulfine gene.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Scott V.E.S., Roch J.-M., Davis-Taber R.A., Molinari E.J., Whiteaker K.L.,
RA   Gopalakrishnan M., Idler K., Sullivan J.P.;
RT   "Cloning and molecular characterization of two isoforms of human
RT   endosulfine.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 6 AND 9).
RC   TISSUE=Placenta, and Pulmonary artery;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=B-cell, Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   INTERACTION WITH SNCA.
RX   PubMed=17893145; DOI=10.1074/jbc.m705283200;
RA   Woods W.S., Boettcher J.M., Zhou D.H., Kloepper K.D., Hartman K.L.,
RA   Ladror D.T., Qi Z., Rienstra C.M., George J.M.;
RT   "Conformation-specific binding of alpha-synuclein to novel protein partners
RT   detected by phage display and NMR spectroscopy.";
RL   J. Biol. Chem. 282:34555-34567(2007).
RN   [14]
RP   INTERACTION WITH SNCA, PHOSPHORYLATION AT SER-109, AND MUTAGENESIS OF
RP   SER-109.
RX   PubMed=18973346; DOI=10.1021/bi801450t;
RA   Boettcher J.M., Hartman K.L., Ladror D.T., Qi Z., Woods W.S., George J.M.,
RA   Rienstra C.M.;
RT   "Membrane-induced folding of the cAMP-regulated phosphoprotein endosulfine-
RT   alpha.";
RL   Biochemistry 47:12357-12364(2008).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2 AND SER-109, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-2 AND SER-109, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-21 AND SER-43, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Protein phosphatase inhibitor that specifically inhibits
CC       protein phosphatase 2A (PP2A) during mitosis. When phosphorylated at
CC       Ser-67 during mitosis, specifically interacts with PPP2R2D (PR55-delta)
CC       and inhibits its activity, leading to inactivation of PP2A, an
CC       essential condition to keep cyclin-B1-CDK1 activity high during M phase
CC       (By similarity). Also acts as a stimulator of insulin secretion by
CC       interacting with sulfonylurea receptor (ABCC8), thereby preventing
CC       sulfonylurea from binding to its receptor and reducing K(ATP) channel
CC       currents. {ECO:0000250, ECO:0000269|PubMed:9653196}.
CC   -!- SUBUNIT: Interacts (when phosphorylated at Ser-67) with PPP2R2D (By
CC       similarity). Interacts with ABCC8. Interacts with SNCA; interaction is
CC       disrupted when phosphorylated at Ser-109. {ECO:0000250,
CC       ECO:0000269|PubMed:17893145, ECO:0000269|PubMed:18973346}.
CC   -!- INTERACTION:
CC       O43768; Q96AP0: ACD; NbExp=2; IntAct=EBI-714511, EBI-717666;
CC       O43768-8; P22607: FGFR3; NbExp=3; IntAct=EBI-25853109, EBI-348399;
CC       O43768-8; Q9UMX0: UBQLN1; NbExp=3; IntAct=EBI-25853109, EBI-741480;
CC       O43768-8; Q9Y649; NbExp=3; IntAct=EBI-25853109, EBI-25900580;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=O43768-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=O43768-2; Sequence=VSP_001443;
CC       Name=3;
CC         IsoId=O43768-3; Sequence=VSP_037065;
CC       Name=4;
CC         IsoId=O43768-4; Sequence=VSP_037066, VSP_001443;
CC       Name=5;
CC         IsoId=O43768-5; Sequence=VSP_037063, VSP_037064;
CC       Name=6;
CC         IsoId=O43768-6; Sequence=VSP_037063, VSP_037064, VSP_001443;
CC       Name=7;
CC         IsoId=O43768-7; Sequence=VSP_037063, VSP_037064, VSP_037065;
CC       Name=8;
CC         IsoId=O43768-8; Sequence=VSP_037067;
CC       Name=9;
CC         IsoId=O43768-9; Sequence=VSP_037065, VSP_001443;
CC   -!- TISSUE SPECIFICITY: Widely expressed with high levels in skeletal
CC       muscle and brain and lower levels in the pancreas.
CC       {ECO:0000269|PubMed:14728987, ECO:0000269|PubMed:9653196}.
CC   -!- PTM: Phosphorylation at Ser-67 by GWL during mitosis is essential for
CC       interaction with PPP2R2D (PR55-delta) and subsequent inactivation of
CC       PP2A (By similarity). Phosphorylated by PKA. {ECO:0000250,
CC       ECO:0000269|PubMed:18973346, ECO:0000269|PubMed:9653196}.
CC   -!- SIMILARITY: Belongs to the endosulfine family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X99906; CAA68180.1; -; mRNA.
DR   EMBL; AJ010966; CAB65125.1; -; Genomic_DNA.
DR   EMBL; AY326403; AAQ73827.1; -; Genomic_DNA.
DR   EMBL; AY326400; AAQ73827.1; JOINED; Genomic_DNA.
DR   EMBL; AY326401; AAQ73827.1; JOINED; Genomic_DNA.
DR   EMBL; AY326402; AAQ73827.1; JOINED; Genomic_DNA.
DR   EMBL; AY326403; AAQ73828.1; -; Genomic_DNA.
DR   EMBL; AY326400; AAQ73828.1; JOINED; Genomic_DNA.
DR   EMBL; AY326401; AAQ73828.1; JOINED; Genomic_DNA.
DR   EMBL; AY326402; AAQ73828.1; JOINED; Genomic_DNA.
DR   EMBL; AY326402; AAQ73829.1; -; Genomic_DNA.
DR   EMBL; AY326400; AAQ73829.1; JOINED; Genomic_DNA.
DR   EMBL; AY326401; AAQ73829.1; JOINED; Genomic_DNA.
DR   EMBL; AY326401; AAQ73830.1; -; Genomic_DNA.
DR   EMBL; AY326400; AAQ73830.1; JOINED; Genomic_DNA.
DR   EMBL; AY326403; AAQ73831.1; -; Genomic_DNA.
DR   EMBL; AY326400; AAQ73831.1; JOINED; Genomic_DNA.
DR   EMBL; AY326401; AAQ73831.1; JOINED; Genomic_DNA.
DR   EMBL; AY326402; AAQ73831.1; JOINED; Genomic_DNA.
DR   EMBL; AY326403; AAQ73832.1; -; Genomic_DNA.
DR   EMBL; AY326400; AAQ73832.1; JOINED; Genomic_DNA.
DR   EMBL; AY326401; AAQ73832.1; JOINED; Genomic_DNA.
DR   EMBL; AY326402; AAQ73832.1; JOINED; Genomic_DNA.
DR   EMBL; AF067170; AAD32454.1; -; mRNA.
DR   EMBL; AF157509; AAF80340.1; -; mRNA.
DR   EMBL; AF157510; AAF80341.1; -; mRNA.
DR   EMBL; AK001981; BAG50998.1; -; mRNA.
DR   EMBL; AK290064; BAF82753.1; -; mRNA.
DR   EMBL; DA888224; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CR749580; CAH18372.1; -; mRNA.
DR   EMBL; CR457130; CAG33411.1; -; mRNA.
DR   EMBL; CR536578; CAG38815.1; -; mRNA.
DR   EMBL; AL356356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53528.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53529.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53530.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53532.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53533.1; -; Genomic_DNA.
DR   EMBL; BC000436; AAH00436.1; -; mRNA.
DR   EMBL; BC004461; AAH04461.1; -; mRNA.
DR   EMBL; BC068544; AAH68544.1; -; mRNA.
DR   EMBL; BC069208; AAH69208.1; -; mRNA.
DR   CCDS; CCDS958.1; -. [O43768-1]
DR   CCDS; CCDS959.1; -. [O43768-3]
DR   CCDS; CCDS960.1; -. [O43768-7]
DR   CCDS; CCDS961.1; -. [O43768-5]
DR   CCDS; CCDS962.1; -. [O43768-9]
DR   CCDS; CCDS963.1; -. [O43768-2]
DR   CCDS; CCDS964.1; -. [O43768-6]
DR   CCDS; CCDS965.1; -. [O43768-8]
DR   RefSeq; NP_004427.1; NM_004436.2. [O43768-1]
DR   RefSeq; NP_996925.1; NM_207042.1. [O43768-3]
DR   RefSeq; NP_996926.1; NM_207043.1. [O43768-9]
DR   RefSeq; NP_996927.1; NM_207044.1. [O43768-2]
DR   RefSeq; NP_996928.1; NM_207045.1. [O43768-7]
DR   RefSeq; NP_996929.1; NM_207046.1. [O43768-5]
DR   RefSeq; NP_996930.1; NM_207047.1. [O43768-6]
DR   RefSeq; NP_997051.1; NM_207168.1. [O43768-8]
DR   AlphaFoldDB; O43768; -.
DR   BMRB; O43768; -.
DR   BioGRID; 108343; 62.
DR   IntAct; O43768; 35.
DR   MINT; O43768; -.
DR   GlyGen; O43768; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O43768; -.
DR   MetOSite; O43768; -.
DR   PhosphoSitePlus; O43768; -.
DR   BioMuta; ENSA; -.
DR   EPD; O43768; -.
DR   jPOST; O43768; -.
DR   MassIVE; O43768; -.
DR   MaxQB; O43768; -.
DR   PeptideAtlas; O43768; -.
DR   PRIDE; O43768; -.
DR   ProteomicsDB; 19158; -.
DR   ProteomicsDB; 49158; -. [O43768-1]
DR   ProteomicsDB; 49159; -. [O43768-2]
DR   ProteomicsDB; 49160; -. [O43768-3]
DR   ProteomicsDB; 49161; -. [O43768-4]
DR   ProteomicsDB; 49162; -. [O43768-5]
DR   ProteomicsDB; 49163; -. [O43768-6]
DR   ProteomicsDB; 49164; -. [O43768-7]
DR   ProteomicsDB; 49165; -. [O43768-8]
DR   TopDownProteomics; O43768-1; -. [O43768-1]
DR   TopDownProteomics; O43768-2; -. [O43768-2]
DR   TopDownProteomics; O43768-3; -. [O43768-3]
DR   TopDownProteomics; O43768-5; -. [O43768-5]
DR   Antibodypedia; 34035; 241 antibodies from 27 providers.
DR   DNASU; 2029; -.
DR   Ensembl; ENST00000271690.12; ENSP00000271690.7; ENSG00000143420.19. [O43768-2]
DR   Ensembl; ENST00000339643.9; ENSP00000341743.5; ENSG00000143420.19. [O43768-3]
DR   Ensembl; ENST00000361532.9; ENSP00000354835.5; ENSG00000143420.19. [O43768-5]
DR   Ensembl; ENST00000361631.9; ENSP00000355239.5; ENSG00000143420.19. [O43768-7]
DR   Ensembl; ENST00000362052.7; ENSP00000355220.7; ENSG00000143420.19. [O43768-8]
DR   Ensembl; ENST00000369014.10; ENSP00000358010.6; ENSG00000143420.19. [O43768-1]
DR   Ensembl; ENST00000503241.1; ENSP00000424242.1; ENSG00000143420.19. [O43768-9]
DR   Ensembl; ENST00000503345.1; ENSP00000421458.1; ENSG00000143420.19. [O43768-8]
DR   Ensembl; ENST00000509582.5; ENSP00000426110.1; ENSG00000143420.19. [O43768-8]
DR   Ensembl; ENST00000513281.5; ENSP00000422343.1; ENSG00000143420.19. [O43768-6]
DR   GeneID; 2029; -.
DR   KEGG; hsa:2029; -.
DR   MANE-Select; ENST00000369014.10; ENSP00000358010.6; NM_004436.4; NP_004427.1.
DR   UCSC; uc001evb.4; human. [O43768-1]
DR   CTD; 2029; -.
DR   DisGeNET; 2029; -.
DR   GeneCards; ENSA; -.
DR   HGNC; HGNC:3360; ENSA.
DR   HPA; ENSG00000143420; Low tissue specificity.
DR   MIM; 603061; gene.
DR   neXtProt; NX_O43768; -.
DR   OpenTargets; ENSG00000143420; -.
DR   PharmGKB; PA27796; -.
DR   VEuPathDB; HostDB:ENSG00000143420; -.
DR   GeneTree; ENSGT00940000155413; -.
DR   HOGENOM; CLU_125025_1_0_1; -.
DR   InParanoid; O43768; -.
DR   OrthoDB; 1494565at2759; -.
DR   PhylomeDB; O43768; -.
DR   TreeFam; TF314718; -.
DR   PathwayCommons; O43768; -.
DR   Reactome; R-HSA-2465910; MASTL Facilitates Mitotic Progression.
DR   SignaLink; O43768; -.
DR   SIGNOR; O43768; -.
DR   BioGRID-ORCS; 2029; 68 hits in 1043 CRISPR screens.
DR   ChiTaRS; ENSA; human.
DR   GeneWiki; ENSA_(gene); -.
DR   GenomeRNAi; 2029; -.
DR   Pharos; O43768; Tbio.
DR   PRO; PR:O43768; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O43768; protein.
DR   Bgee; ENSG00000143420; Expressed in cervix squamous epithelium and 204 other tissues.
DR   ExpressionAtlas; O43768; baseline and differential.
DR   Genevisible; O43768; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0008200; F:ion channel inhibitor activity; TAS:ProtInc.
DR   GO; GO:0019212; F:phosphatase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IDA:MGI.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; IBA:GO_Central.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; ISS:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IDA:MGI.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IBA:GO_Central.
DR   GO; GO:0050796; P:regulation of insulin secretion; IDA:MGI.
DR   GO; GO:0007584; P:response to nutrient; TAS:ProtInc.
DR   InterPro; IPR006760; Endosulphine.
DR   PANTHER; PTHR10358; PTHR10358; 1.
DR   Pfam; PF04667; Endosulfine; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell cycle; Cell division; Cytoplasm;
KW   Mitosis; Phosphoprotein; Protein phosphatase inhibitor; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   CHAIN           2..121
FT                   /note="Alpha-endosulfine"
FT                   /id="PRO_0000146758"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          79..121
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..40
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        102..121
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         21
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         43
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         67
FT                   /note="Phosphoserine; by GWL"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         109
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:18973346,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692"
FT   VAR_SEQ         1..4
FT                   /note="Missing (in isoform 5, isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037063"
FT   VAR_SEQ         5..19
FT                   /note="QEEENPAEETGEEKQ -> MAGGLGCDVCYWFVE (in isoform 5,
FT                   isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037064"
FT   VAR_SEQ         61
FT                   /note="G -> GDYKSLHWSVLLCADEM (in isoform 3, isoform 7 and
FT                   isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037065"
FT   VAR_SEQ         61
FT                   /note="G -> GVWGIASYPLSLGLKEVLRMKSVE (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_037066"
FT   VAR_SEQ         62..121
FT                   /note="QKYFDSGDYNMAKAKMKNKQLPSAGPDKNLVTGDHIPTPQDLPQRKSSLVTS
FT                   KLAGGQVE -> VWGIVSYPLSLELKEVLRMKSVEVLLDPFLEVLLLNRSRGEFEI
FT                   (in isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_037067"
FT   VAR_SEQ         118..121
FT                   /note="Missing (in isoform 2, isoform 4, isoform 6 and
FT                   isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|Ref.5, ECO:0000303|Ref.8"
FT                   /id="VSP_001443"
FT   MUTAGEN         109
FT                   /note="S->E: Mimicks a phosphorylated state and impairs
FT                   interaction with SNCA."
FT                   /evidence="ECO:0000269|PubMed:18973346"
FT   CONFLICT        5
FT                   /note="Q -> R (in Ref. 8; CAG38815)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        21
FT                   /note="T -> M (in Ref. 6; BAF82753)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        22
FT                   /note="Q -> L (in Ref. 11; AAH68544)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="K -> Q (in Ref. 8; CAG33411)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   121 AA;  13389 MW;  7C76315AA17E7542 CRC64;
     MSQKQEEENP AEETGEEKQD TQEKEGILPE RAEEAKLKAK YPSLGQKPGG SDFLMKRLQK
     GQKYFDSGDY NMAKAKMKNK QLPSAGPDKN LVTGDHIPTP QDLPQRKSSL VTSKLAGGQV
     E
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024